Rani Therapeutics raises $20M via common stock and pre-funded warrant offering

Rani Therapeutics Holdings, Inc.

Issues 12.48M shares at $1.07/share and pre-funded warrants for 6.21M shares at $1.0699.
Gross proceeds of ~$20M; closing expected May 27, 2026.
Placement agents: H.C. Wainwright & Co. and Chardan Capital Markets; lock-up agreements for 60 days.
Offering made under effective S-3 registration statement filed August 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.